Qiagen
QGEN

Qiagen (QGEN) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
BarclaysUpgradedEqual-Weight → Overweight$55.00 from $40.00Oct 6, 2026
UBSMaintainedNeutral$47.00 from $52.00Sep 9, 2026
CitigroupMaintainedNeutral$45.00 from $38.00Aug 10, 2026
JP MorganMaintainedOverweight$50.00 from $45.00Aug 7, 2026
BarclaysMaintainedEqual-Weight$40.00 from $38.00Aug 7, 2026
Morgan StanleyUpgradedEqual-Weight → Overweight$42.00 from $40.00Jun 23, 2026
StifelMaintainedHold$36.00 from $50.00May 18, 2026
TD CowenMaintainedHold$40.00 from $46.00May 7, 2026
BarclaysMaintainedEqual-Weight$38.00 from $44.00Apr 29, 2026
BairdUpgradedNeutral → Outperform$43.00 from $53.00Apr 29, 2026
CitigroupMaintainedNeutral$38.00 from $55.00Apr 29, 2026
JP MorganMaintainedOverweight$45.00 from $60.00Apr 29, 2026
BarclaysDowngradedOverweight → Equal-Weight$44.00Apr 14, 2026
Deutsche BankUpgradedHold → Buy$54.00Mar 13, 2026
StifelMaintainedHold$50.00 from $45.00Feb 6, 2026
CitigroupMaintainedNeutral$55.00 from $55.40Feb 6, 2026
JP MorganMaintainedOverweight$60.00 from $55.00Feb 6, 2026
Deutsche BankDowngradedBuy → Hold$54.00 from $52.00Jan 22, 2026
BarclaysMaintainedOverweight$55.00 from $53.00Dec 15, 2025
CitigroupDowngradedBuy → Neutral$50.00 from $55.00Dec 11, 2025

Frequently asked questions

  • What is the latest analyst rating on QGEN?

    On Oct 6, 2026, Barclays upgraded Qiagen to Overweight with a price target of $55.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.